A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT)
Abstract
In the typical prevention of mother to child transmission (PMTCT) of HIV cascade of care discussion or analysis, the period of analysis begins at the first visit for antenatal care (ANC) for that pregnancy. This starting point is problematic for two reasons: (1) a large number of HIV-infected women are already on life-long antiretroviral therapy (ART) when presenting for ANC; and (2) women present to ANC at different gestational ages. The PMTCT ART Coverage Tool (PMTCT-ACT), which estimates the proportion of days covered (PDC) with ART, was developed to address each of these problems.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 15, 2019
- Source ID
- 10.1186/s41256-019-0121-3
Entities
People
- Bruce A. Larson
- Isaac Tsikhutsu
- Margaret Bii
- Nafisa Halim
- Peter C. Rockers
- Peter Coakley
Organizations
- Walter Reed Army Institute of Research